“tvm-capital” Archives

Entry Author Date Location
Acer Therapeutics Lands $8,150,000 Series B Financing 05/11/16 Boston
Argos Nabs Up to $60M to Continue Kidney Cancer Treatment Work 03/07/16 Raleigh Durham
Fresh Off Boston Move, CoLucid Plots IPO For Migraine Drug Push 03/31/15 Raleigh Durham
Migraine Drug Developer CoLucid Lands $37.1M for Phase 3 Trial 01/13/15 Raleigh Durham
Proteon Cuts Price, Boosts Shares to Bag $61M in IPO 10/22/14 Boston
Proteon, Moving on From Ill-Fated Novartis Deal, Files IPO Pitch 09/16/14 Boston
Bluebird’s Gene Therapy Quickly Halts Blood Disease in Small Study 06/14/14 Boston
With Novartis Deal Dead, Proteon Embarks on Plan B With $45M Round 05/16/14 Boston
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share 02/13/14 Boston
Rapid Micro Biosystems Obtains $32,600,000 Series B Funding Round 06/26/13 Boston
Bluebird Prices Ahead of Range, Takes Flight on Nasdaq Today 06/19/13 Boston
Bluebird Bio Snags $60M From Existing VCs and Newcomers Like Shire 07/25/12 Boston
eBay Acquires Where, Bluebird Calls In $30M, Humedica Gets $20M, & More Boston-Area Deals News 04/27/11 Boston
Bluebird Bio Snaps up $30M for Gene Therapies, Adds ARCH Venture to Syndicate 04/20/11 Boston
bluebird bio Receives $30,000,000 Series C Financing Round 04/20/11 Boston
Intel Buys NVP-backed Silicon Hive 03/17/11 San Francisco
Bluebird Bio Inks AFM Development Deal 03/16/11 Boston
Q&A on Startups and Investing Strategy with Massachusetts Clean Energy Center’s “State Angel” Arif Padaria 12/15/10 Boston
Cerenis Adds $13.9M to C Round 10/21/10 Detroit Ann Arbor
Anchor Therapeutics Hooks Deal Worth Up to $480M with J&J 09/09/10 Boston
MedNetworks Partners with Healthways, NKT Gets $4M, Aileron Lands Deal With Roche, & More Boston-Area Life Sciences News 08/27/10 Boston
Cisco to Acquire ExtendMedia, Strengthen Position in Internet Video Delivery 08/26/10 Boston
Anchor Sinks $10M Series B, Aileron Lands Deal with Roche, C Change Launches Fund With Vanterra, & More Boston-Area Deals News 08/25/10 Boston
Anchor Therapeutics Nabs $10M for New Class of Peptide Drugs Against Hard Targets 08/20/10 Boston
Anchor Therapeutics Obtains $10,000,000 New Financing 08/20/10 Boston
Ann Arbor’s Cerenis Therapeutics Gets $51.7M to Develop Drug for Cardiovascular Disease 07/26/10 Detroit Ann Arbor
Genetix Gets $35M for Gene Therapy, FDA Delays Decision on Alkermes/Amylin Drug, MedMinder and Vitality Tackle Medication Compliance, & More Boston-Area Life Sciences News 03/19/10 Boston
Genetix Pharma Raises $35M from Third Rock, Genzyme for Gene Therapy 03/12/10 Boston
GENETIX Pharmaceuticals Garners $35,000,000 Series B Round 03/12/10 Boston
Bitwave Raises $1.3M of $6M Round 11/06/09 Boston
Page 1 of 2 next page »